Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Country/Region

Topic

April 03, 2017

On Sunday, April 2, Doctors Without Borders/Médecins Sans Frontières (MSF) sent a multidisciplinary team consisting of a coordinator, a doctor, a nurse, a psychologist, and a logistician to Mocoa, Colombia, to assess the medical needs of people affected by this weekend's landslides.

The teams traveled to different parts of Colombia, where for 15 years MSF has provided primary, mental and sexual and reproductive health care to victims of armed conflict and violence in isolated populations in twenty departments of the country.

March 31, 2017

In Tal Afar District, northwest of Mosul, a dire lack of functional medical facilities is preventing the population from accessing health care. In response, MSF is expanding its activities in the area, opening a maternity clinic in October 2016 and, more recently, a stabilization unit and children’s ward in the village of Tal Maraq.

March 31, 2017

NEW YORK, MARCH 31, 2017—A hospital in northern Syria that receives support from the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) was bombed on March 25, killing two people and causing severe respiratory symptoms among patients and staff, MSF said today, denouncing the attack.

March 31, 2017

Brazilian administrator Fabio Biolchini just returned from a year with the Doctors Without Borders/Médecins Sans Frontières(MSF) emergency team, responding to epidemics and other crises across the breadth of Democratic Republic of Congo (DRC). Here, he reflects on his experiences.

I’ve just come back from DRC, where I lived for one year on my fourth assignment with MSF, after working in Haiti, Turkey, and Central African Republic.

March 31, 2017

This short 360° documentary from the Financial Times follows a child with typhoid, explains how an outbreak spreads in the Democratic Republic of Congo (DRC), and how Doctors Without Borders/Médecins Sans Frontières (MSF) responds.

Use your mouse to drag the view from side to side, up and down. Or use the gray button in the top left corner of the video.

March 27, 2017

Cervical cancer rates are on the rise worldwide, but the brunt of the burden falls on low- and middle-income countries, where more than 80 percent of cases occur and many women have little or no access to health services for prevention, curative treatment, or palliative care. 

March 27, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) began supporting the Zimbabwean health ministry in 2016, rolling out services to prevent cervical cancer at health centers in Gutu district. MSF teams provide mentoring, ongoing training, and supervision for Zimbabwean nurses, as well as equipment and technical support. Here are stories from some of our patients:

March 27, 2017

First patent opposition MSF has filed in Europe aims to increase affordable access to hepatitis C drug sofosbuvir for millions

NEW YORK/ROME/GENEVA, MARCH 27, 2017—In an effort to increase access to affordable hepatitis C treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) filed a patent challenge on the lifesaving hepatitis C drug sofosbuvir with the European Patent Office (EPO) today.

March 24, 2017

Patients with drug-resistant tuberculosis (MDR-TB) have to take a fistful of pills and injections daily for up to two years. Side effects of these toxic drugs can include permanent deafness, nausea and vomiting, blindness, and psychosis. After decades without any new TB drugs, two powerful, less toxic medicines were finally released five years ago. But most patients can't get access to them. This needs to change.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

Pages